Terms: = Endocrine gland cancer AND ERBB4, MGC138404, 2066, ENSG00000178568, Q15303, p180erbB4, HER4 AND Diagnosis
6 results:
1. miR-326 inhibits the progression of papillary thyroid carcinoma by targeting MAPK1 and erbb4.
Nie FR; Li QX; Wei HF; Ma Y
Neoplasma; 2020 May; 67(3):604-613. PubMed ID: 32266816
[TBL] [Abstract] [Full Text] [Related]
2. Review of our experience with neuroblastoma and ganglioneuroblastoma in adults.
Jrebi NY; Iqbal CW; Joliat GR; Sebo TJ; Farley DR
World J Surg; 2014 Nov; 38(11):2871-4. PubMed ID: 25002244
[TBL] [Abstract] [Full Text] [Related]
3. Ligand stimulation of erbb4 and a constitutively-active erbb4 mutant result in different biological responses in human pancreatic tumor cell lines.
Mill CP; Gettinger KL; Riese DJ
Exp Cell Res; 2011 Feb; 317(4):392-404. PubMed ID: 21110957
[TBL] [Abstract] [Full Text] [Related]
4. Development of acromegaly in patients with prolactinomas.
Andersen M; Hagen C; Frystyk J; Schroeder HD; Hagen C
Eur J Endocrinol; 2003 Jul; 149(1):17-22. PubMed ID: 12824861
[TBL] [Abstract] [Full Text] [Related]
5. Incidentally discovered adrenal masses: a functional and morphological study.
Corsello SM; Della Casa S; Bollanti L; Rufini V; Rota CA; Danza F; Colasanti S; Vellante C; Troncone L; Barbarino A
Exp Clin Endocrinol; 1993; 101(3):131-7. PubMed ID: 8223980
[TBL] [Abstract] [Full Text] [Related]
6. Incidentally discovered adrenal tumors: an institutional perspective.
Herrera MF; Grant CS; van Heerden JA; Sheedy PF; Ilstrup DM
Surgery; 1991 Dec; 110(6):1014-21. PubMed ID: 1745970
[TBL] [Abstract] [Full Text] [Related]
